BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34821250)

  • 1. Advances in decomposing complex metabolite mixtures using substructure- and network-based computational metabolomics approaches.
    Beniddir MA; Kang KB; Genta-Jouve G; Huber F; Rogers S; van der Hooft JJJ
    Nat Prod Rep; 2021 Nov; 38(11):1967-1993. PubMed ID: 34821250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good practices and recommendations for using and benchmarking computational metabolomics metabolite annotation tools.
    de Jonge NF; Mildau K; Meijer D; Louwen JJR; Bueschl C; Huber F; van der Hooft JJJ
    Metabolomics; 2022 Dec; 18(12):103. PubMed ID: 36469190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking.
    Zhou Z; Luo M; Zhang H; Yin Y; Cai Y; Zhu ZJ
    Nat Commun; 2022 Nov; 13(1):6656. PubMed ID: 36333358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering complex metabolite mixtures by unsupervised and supervised substructure discovery and semi-automated annotation from MS/MS spectra.
    Rogers S; Ong CW; Wandy J; Ernst M; Ridder L; van der Hooft JJJ
    Faraday Discuss; 2019 Aug; 218(0):284-302. PubMed ID: 31120050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A novel method for efficient screening and annotation of important pathway-associated metabolites based on the modified metabolome and probe molecules].
    Li Z; Zheng F; Xia Y; Zhang X; Wang X; Zhao C; Zhao X; Lu X; Xu G
    Se Pu; 2022 Sep; 40(9):788-796. PubMed ID: 36156625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and Limitations for Untargeted Mass Spectrometry Metabolomics to Identify Biologically Active Constituents in Complex Natural Product Mixtures.
    Caesar LK; Kellogg JJ; Kvalheim OM; Cech NB
    J Nat Prod; 2019 Mar; 82(3):469-484. PubMed ID: 30844279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR in metabolomics and natural products research: two sides of the same coin.
    Robinette SL; Brüschweiler R; Schroeder FC; Edison AS
    Acc Chem Res; 2012 Feb; 45(2):288-97. PubMed ID: 21888316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topic modeling for untargeted substructure exploration in metabolomics.
    van der Hooft JJ; Wandy J; Barrett MP; Burgess KE; Rogers S
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13738-13743. PubMed ID: 27856765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR as a tool for compound identification in mixtures.
    Borges RM; Ferreira GA; Campos MM; Teixeira AM; Costa FDN; das Chagas FO; Colonna M
    Phytochem Anal; 2023 Jun; 34(4):385-392. PubMed ID: 37128872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in metabolite identification.
    Wishart DS
    Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomous METLIN-Guided In-source Fragment Annotation for Untargeted Metabolomics.
    Domingo-Almenara X; Montenegro-Burke JR; Guijas C; Majumder EL; Benton HP; Siuzdak G
    Anal Chem; 2019 Mar; 91(5):3246-3253. PubMed ID: 30681830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate Identification of Unknown and Known Metabolic Mixture Components by Combining 3D NMR with Fourier Transform Ion Cyclotron Resonance Tandem Mass Spectrometry.
    Wang C; He L; Li DW; Bruschweiler-Li L; Marshall AG; Brüschweiler R
    J Proteome Res; 2017 Oct; 16(10):3774-3786. PubMed ID: 28795575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role that spectral libraries play in capturing the metabolomics community knowledge.
    Bittremieux W; Wang M; Dorrestein PC
    Metabolomics; 2022 Nov; 18(12):94. PubMed ID: 36409434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MESSAR: Automated recommendation of metabolite substructures from tandem mass spectra.
    Liu Y; Mrzic A; Meysman P; De Vijlder T; Romijn EP; Valkenborg D; Bittremieux W; Laukens K
    PLoS One; 2020; 15(1):e0226770. PubMed ID: 31945070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Structure-Guided Molecular Network Strategy for Global Untargeted Metabolomics Data Annotation.
    Wang X; Li C; Li Z; Qi Y; Zhang X; Zhao X; Zhao C; Lin X; Lu X; Xu G
    Anal Chem; 2023 Aug; 95(31):11603-11612. PubMed ID: 37493263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding Urinary Metabolite Annotation through Integrated Mass Spectral Similarity Networking.
    Neto FC; Raftery D
    Anal Chem; 2021 Sep; 93(35):12001-12010. PubMed ID: 34436864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational strategies for metabolite identification in metabolomics.
    Wishart DS
    Bioanalysis; 2009 Dec; 1(9):1579-96. PubMed ID: 21083105
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.